CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 128 enrolled
Drug / intervention
Epinephrine +2 moredrug
Likely dose
Epinephrine 1 mLfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04594408
NCT04594408Phase 4Completed

The Use of Tranexamic Acid in Irrigation Fluid to Improve Arthroscopic Visualization in Shoulder Surgery: A Randomized Controlled Trial

Panam Clinic·interventional·Posted Oct 20, 2020·Updated Apr 2, 2024

In Brief

A Phase 4 clinical trial evaluating Epinephrine, Tranexamic acid, and 1 other intervention for Rotator Cuff Injuries and 3 related conditions. Completed, enrolled 128 participants across 1 site.

Detailed Summary

The purpose of this study is to determine if intravenous TXA is a safe alternative to epinephrine in improving arthroscopic shoulder visualization. Primary Objectives 1. Determine that patients given intravenous tranexamic acid improves surgeon-rated visualization compared to placebo. 2. Determine that intravenous tranexamic acid is a safe alternative to epinephrine mixed irrigation fluid to improve arthroscopic shoulder visualization

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesCanada

Timeline

Phase 4CompletedFinished
202120222023202420252026
First PostedOct 20, 2020
Enrollment StartSep 1, 2020
Primary CompletionOct 1, 2021
Study CompletionJan 1, 2024
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 5.7 years ago

Interventions

Epinephrinedrug

1 mL of 1:1000 mixed into irrigation bag.

Tranexamic aciddrug

1 g IV x 1 dose to be administered intraoperatively.

Epinephrine and Tranexamic Aciddrug

1 mL of 1:1000 epinephrine mixed into irrigation bag, and 1 g tranexamic acid x 1 dose to be administered intraoperatively.